Clinical characteristics and risk factors of drug‐induced lung injury by ALK tyrosine kinase inhibitors: A single center retrospective analysis

BACKGROUND: If anaplastic lymphoma kinase (ALK) gene rearrangement in lung cancer is identified, ALK‐tyrosine kinase inhibitors (ALK‐TKIs) can be an effective treatment. However, the details of drug‐induced lung injury (DILI) caused by ALK‐TKI, which can be a serious side effect of ALK‐TKIs, remains...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Thorac Cancer
Main Authors: Koshikawa, Ken, Terada, Jiro, Abe, Mitsuhiro, Iwasawa, Shunichiro, Sakayori, Masashi, Yoshioka, Keiichiro, Hirasawa, Yasutaka, Kasai, Hajime, Kawasaki, Yohei, Tsushima, Kenji, Tatsumi, Koichiro
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons Australia, Ltd 2020
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7262910/
https://ncbi.nlm.nih.gov/pubmed/32237210
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.13416
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados